‪Jayanthi Lea. M.D.; F.A.C.O.G.; F.A.C.S.‬

Citée par

	Toutes	Depuis 2020
Citations	4324	2945
indice h	34	25
indice i10	74	53

860

430

215

645

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202521 48 43 47 44 54 64 54 66 88 62 74 101 137 166 263 336 440 545 627 854 127

Accès public

Tout afficher

32 articles

3 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

David Scott MillerUniversity of Texas Southwestern Medical CenterAdresse e-mail validée de UTSouthwestern.edu
Kevin AlbuquerqueDepartment of Radiation Oncology UT Southwestern Medical CenterAdresse e-mail validée de utsouthwestern.edu
W. Lee KrausUniversity of Texas Southwestern Medical CenterAdresse e-mail validée de utsouthwestern.edu
Diego H. CastrillonUT SouthwesternAdresse e-mail validée de utsouthwestern.edu
Yang-Xin FuTsinghua UniversityAdresse e-mail validée de tsinghua.edu.cn
Jinming GaoUT Southwestern Medical CenterAdresse e-mail validée de utsouthwestern.edu
TULIP NANDUUT Southwestern Medical Center, Dallas, Texas, USAAdresse e-mail validée de utsouthwestern.edu
Zhigang LuFudan UniversityAdresse e-mail validée de fudan.edu.cn
John MinnaProfessor of Internal Medicine and Pharmacology, University of Texas Southwestern Medical CenterAdresse e-mail validée de utsouthwestern.edu
Yang LiU.S. Food and Drug AdministrationAdresse e-mail validée de utsouthwestern.edu
Haocheng CaiKaiser Permanente Los Angeles Medical CenterAdresse e-mail validée de utsouthwestern.edu
Matthew R. PorembkaUT Southwestern Medical SchoolAdresse e-mail validée de UTSouthwestern.edu
Chensu WangThe Koch Institute for Integrative Cancer Research at MITAdresse e-mail validée de mit.edu
Rolf BrekkenUT SouthwesternAdresse e-mail validée de utsouthwestern.edu
Yao DingThe University of Texas, MD Anderson Cancer CenterAdresse e-mail validée de mdanderson.org
Ralph P MasonProfessor of Radiology, The University of Texas Southwestern Medical CenterAdresse e-mail validée de UTSouthwestern.edu
Adi GazdarProfessor of Pathology, UT Southwestern Medical CenterAdresse e-mail validée de utsouthwestern.edu
Martee HensleyMemorial Sloan KetteringAdresse e-mail validée de mskcc.org
Jean-yves BlayProfesseur de Cancérologie Centre Leon Berard & University Claude Bernard Lyon IAdresse e-mail validée de lyon.unicancer.fr
Xiang ChenProfessor of Electrical and Computer Engineering, University of WindsorAdresse e-mail validée de uwindsor.ca

Suivre

Jayanthi Lea. M.D.; F.A.C.O.G.; F.A.C.S.

Professor, Director - Gynecologic Oncology Fellowship Program; UT Southwestern Medical

Adresse e-mail validée de utsouthwestern.edu

Gynecologic Oncology Ovarian Cancer Peritoneal Cancer Cytoreductive Surgery Minimally Invasive Surgery


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
A STING-activating nanovaccine for cancer immunotherapy M Luo, H Wang, Z Wang, H Cai, Z Lu, Y Li, M Du, G Huang, C Wang, ... Nature nanotechnology 12 (7), 648-654, 2017	839	2017
Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology N Abu-Rustum, C Yashar, R Arend, E Barber, K Bradley, R Brooks, ... Journal of the National Comprehensive Cancer Network 21 (2), 181-209, 2023	284	2023
NCCN Guidelines® insights: uterine neoplasms, version 3.2021: featured updates to the NCCN guidelines NR Abu-Rustum, CM Yashar, K Bradley, SM Campos, J Chino, HS Chon, ... Journal of the National Comprehensive Cancer Network 19 (8), 888-895, 2021	141	2021
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024: Featured Updates to the NCCN Guidelines NR Abu-Rustum, CM Yashar, R Arend, E Barber, K Bradley, R Brooks, ... Journal of the National Comprehensive Cancer Network 21 (12), 1224-1233, 2023	110	2023
Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II MHM Oonk, B Slomovitz, PJW Baldwin, HC Van Doorn, J Van der Velden, ... Journal of Clinical Oncology 39 (32), 3623-3632, 2021	107	2021
Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study J Lea, R Sharma, F Yang, H Zhu, ES Ward, AJ Schroit Oncotarget 8 (9), 14395, 2017	107	2017
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment CG Peña, Y Nakada, HD Saatcioglu, GM Aloisio, I Cuevas, S Zhang, ... The Journal of clinical investigation 125 (11), 4063-4076, 2015	94	2015
Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma JG Bell, JS Lea, GC Reid Gynecologic oncology 77 (2), 314-318, 2000	92	2000
Cervical cancer JS Lea, KY Lin Obstetrics and Gynecology Clinics 39 (2), 233-253, 2012	91	2012
A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer K Albuquerque, V Tumati, J Lea, C Ahn, D Richardson, D Miller, ... International Journal of Radiation Oncology* Biology* Physics 106 (3), 464-471, 2020	90	2020
Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy M Luo, Z Liu, X Zhang, C Han, LZ Samandi, C Dong, BD Sumer, J Lea, ... Journal of Controlled Release 300, 154-160, 2019	88	2019
Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma JS Lea, RL Coleman, EO Garner, LR Duska, DS Miller, JO Schorge Gynecologic oncology 91 (3), 558-562, 2003	87	2003
Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: a phase III NRG oncology/gynecologic oncology group study ML Hensley, D Enserro, H Hatcher, PB Ottevanger, A Krarup-Hansen, ... Journal of Clinical Oncology 36 (33), 3324-3330, 2018	85	2018
De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection D Beshnova, J Ye, O Onabolu, B Moon, W Zheng, YX Fu, J Brugarolas, ... Science translational medicine 12 (557), eaaz3738, 2020	81	2020
Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ JS Lea, CH Shin, EE Sheets, RL Coleman, PA Gehrig, LR Duska, ... Gynecologic oncology 87 (1), 129-132, 2002	81	2002
Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level‐dependent (BOLD) MRI at 3T RR Hallac, Y Ding, Q Yuan, RW McColl, J Lea, RD Sims, PT Weatherall, ... NMR in biomedicine 25 (12), 1321-1330, 2012	77	2012
Stage IIB–IVB cervical adenocarcinoma: prognostic factors and survival JS Lea, EE Sheets, RM Wenham, LR Duska, RL Coleman, DS Miller, ... Gynecologic oncology 84 (1), 115-119, 2002	77	2002
A phase I-II evaluation of veliparib (NSC# 737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an … C Kunos, W Deng, D Dawson, JS Lea, KM Zanotti, HJ Gray, DP Bender, ... International Journal of Gynecologic Cancer 25 (3), 2015	73	2015
P16 as a molecular biomarker of cervical adenocarcinoma JO Schorge, JS Lea, KJ Elias, R Rajanbabu, RL Coleman, DS Miller, ... American journal of obstetrics and gynecology 190 (3), 668-673, 2004	73	2004
Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells JS Lea, N Sunaga, M Sato, G Kalahasti, DS Miller, JD Minna, CY Muller Reproductive sciences 14, 20-28, 2007	70	2007

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs